CTOs on the Move

Seqirus

www.seqirus.com

 
Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. Seqirus has a workforce of over 2,000 employees, significant manufacturing capacity and a ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.seqirus.com
  • 475 Green Oaks Parkway
    Holly Springs, NC USA 27540
  • Phone: 919.577.5000

Executives

Name Title Contact Details

Similar Companies

Aratana Therapeutics

Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for cats and dogs.

Exeter Group

Exeter Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aeras Global TB Vaccine Foundation

Aeras is constantly producing new constructs that will also be made available following phenotypic, genotypic and stability characterization. Aeras is also glad to provide shigella carrier strains with capsids expressing TB antigens under similar

DrugSense

DrugSense is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MIDi

MIDi is a Springfield, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.